Close-monitor your Competitor's Move, Request sample copy
Growing Pharmaceutical R&D Investments and Regulations
The pharmaceutical industry is among the major end users of molecular spectroscopy techniques for new drug discovery and development. With rising healthcare expenditures, an aging global population and increasing prevalence of chronic diseases, pharmaceutical R&D investments have grown substantially over the past decade. According to reports, over 150 billion dollars are spent annually on pharmaceutical R&D globally. A significant portion of these funds goes towards analytical characterization and testing of drug molecules, metabolites and formulations at various stages - from early discovery to commercial manufacturing. Moreover, regulatory standards by authorities like FDA and EMA have also become more stringent over the years. For instance, in October 2020, Bruker Corporation unveiled the Fourier 80 system in Europe, a benchtop spectrometer utilizing nuclear magnetic resonance (FT-NMR) technology. Additionally, numerous advancements are anticipated to drive notable market expansion throughout the projected period.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients